| Field | Specification |
|---|---|
| Target | |
| Alternative names | RNA polymerase II elongation factor ELL; Eleven-nineteen lysine-rich leukemia protein; ELL; C19orf17 |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | E.coli-derived human ELL recombinant protein (Position: M1-S407). |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody recognizes RNA polymerase II elongation factor ELL in human samples and is validated for Western blot, ICC/IF, flow cytometry and ELISA. The predicted molecular weight is 68.3 kDa, and the supplier reports an observed band at about 60–80 kDa.
ELL is an RNA polymerase II elongation factor that reduces transcriptional pausing. It is part of the super elongation complex, which releases paused polymerase, and of the little elongation complex, which aids small nuclear RNA transcription. ELL is also a fusion partner of MLL in some leukemias.
| Target | RNA polymerase II elongation factor ELL (gene ELL; UniProt P55199, human) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Human |
| Form | Lyophilized |
| Formulation | Per vial: 4 mg trehalose; 0.9 mg NaCl; 0.2 mg Na2HPO4 |
| Calculated MW | 68.3 kDa |
| Observed MW | 60–80 kDa |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 0.25–0.5 µg/mL (Human) |
|---|---|
| Immunocytochemistry / Immunofluorescence | 5 µg/mL (Human) |
| Flow cytometry (fixed cells) | 1–3 µg/1×106 cells (Human) |
| ELISA | 0.1–0.5 µg/mL |
Samples with a confirmed band (WB): human HeLa cells, human HEK293 cells, human HL-60 cells.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 5–20% gradient SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 0.5 µg/mL overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (ICC/IF): A431 cells.
Samples with a confirmed signal (flow cytometry): 293T cells.
Immunogen
Recombinant human ELL fragment (Met1–Ser407), expressed in E. coli.
Reactivity Notes
The supplier lists reactivity with human. UniProt places RNA polymerase II elongation factor ELL in the nucleus and nucleus speckle. Tissue expression noted by UniProt (human): Expressed in all tissues tested. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
